|
1
|
Sperti C, Pasquali C, Piccoli A and
Pedrazzoli S: Survival after resection for ductal adenocarcinoma of
the pancreas. Br J Surg. 83:625–631. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Toyoda H, Kumada T, Nakano S, Takeda I,
Sugiyama K, Kiriyama S, Tanikawa M, Sone Y and Hisanaga Y: Impact
of diabetes mellitus on the prognosis of patients with
hepatocellular carcinoma. Cancer. 91:957–963. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yancik R, Wesley MN, Ries LA, Havlik RJ,
Edwards BK and Yates JW: Effect of age and comorbidity in
postmenopausal breast cancer patients aged 55 years and older.
JAMA. 285:885–892. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Giorgio R, Barbara G, Cecconi A,
Corinaldesi R and Mancini AM: Diabetes is associated with longer
survival rates in patients with malignant tumors. Arch Intern Med.
160:22172000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hatlen P, Grønberg BH, Langhammer A,
Carlsen SM and Amundsen T: Prolonged survival in patients with lung
cancer with diabetes mellitus. J Thorac Oncol. 6:1810–1817. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanbali A, Al-Khasawneh K, Cole-Johnson C,
Divine G and Ali H: Protective effect of diabetes against
metastasis in patients with non-small cell lung cancer. Arch Intern
Med. 167:5132007.PubMed/NCBI
|
|
7
|
Satoh H, Ishikawa H, Kurishima K, Ohtsuka
M and Sekizawa K: Diabetes is not associated with longer survival
in patients with lung cancer. Arch Intern Med. 161:4852001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tammemagi CM, Neslund-Dudas C, Simoff M
and Kvale P: Impact of comorbidity on lung cancer survival. Int J
Cancer. 103:792–802. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vasić L: Locally advanced non-small cell
lung cancer-pretreatment prognostic factors: Disease stage, tumor
histopathological characteristics, the patient-related factors.
Arch Oncol. 15:19–23. 2007. View Article : Google Scholar
|
|
10
|
Emerging Risk Factors Collaboration, ;
Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P,
Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, et al: Diabetes
mellitus, fasting glucose, and risk of cause-specific death. N Engl
J Med. 364:829–841. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo J, Chen YJ and Chang LJ: Fasting blood
glucose level and prognosis in non-small cell lung cancer (NSCLC)
patients. Lung Cancer. 76:242–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lababede O, Meziane M and Rice T: Seventh
edition of the cancer staging manual and stage grouping of lung
cancer: Quick reference chart and diagrams. Chest. 139:183–189.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cox DR: Regression models and life tables.
J Roy Stat Soc B. 34:187–220. 1972.
|
|
14
|
Vlassara H: Recent progress in advanced
glycation end products and diabetic complications. Diabetes. 46
Suppl 2:S19–S25. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nerlich AG, Hagedon HG, Böheim M and
Schleicher ED: Patients with diabetes-induced microangiopathy show
a reduced frequency of carcinomas. In Vivo. 12:667–670.
1998.PubMed/NCBI
|
|
16
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Danaei G, Finucane MM, Lu Y, Singh GM,
Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA,
et al: National, regional, and global trends in fasting plasma
glucose and diabetes prevalence since 1980: Systematic analysis of
health examination surveys and epidemiological studies with 370
country-years and 2·7 million participants. Lancet. 378:31–40.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van de Poll-Franse LV, Houterman S,
Janssen-Heijnen ML, Dercksen MW, Coebergh JW and Haak HR: Less
aggressive treatment and worse overall survival in cancer patients
with diabetes: A large population based analysis. Int J Cancer.
120:1986–1992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Richardson LC and Pollack LA: Therapy
insight: Influence of type 2 diabetes on the development, treatment
and outcomes of cancer. Nat Clin Pract Oncol. 2:48–53. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rosenzweig SA and Atreya HS: Defining the
pathway to insulin-like growth factor system targeting in cancer.
Biochem Pharmacol. 80:1115–1124. 2010. View Article : Google Scholar : PubMed/NCBI
|
